NCT04947124 2025-01-20A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101Qlaris Bio, Inc.Phase 2 Completed3 enrolled
NCT05495269 2025-01-20Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)Qlaris Bio, Inc.Phase 2 Completed2 enrolled
NCT01997255 2016-05-05Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)Baylor College of MedicinePhase 2 Withdrawn